Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Microsoft To Power Moody’s Next-Generation Solutions With Azure OpenAI Service

Moody's Corp (NYSE: MCO) tapped Microsoft Corp (NASDAQ: MSFT) to deliver next-generation data, analytics, research, collaboration, and risk solutions for financial services and 
byAnusuya Lahiri
June 29, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Moody’s Corp (NYSE:MCO) tapped Microsoft Corp (NASDAQ:MSFT) to deliver next-generation data, analytics, research, collaboration, and risk solutions for financial services and global knowledge workers. 

Built on a combination of Moody’s data and analytical capabilities and the power and scale of Microsoft Azure OpenAI Service, the partnership creates innovative offerings that enhance insights into corporate intelligence and risk assessment, powered by Microsoft AI and anchored by Moody’s proprietary data, analytics and research.

Also Read: Why Moody’s Stock Is Gaining Today

The ratings and research firm activated its 14,000 global employees to drive experimentation and innovations across its suite of products and solutions.

OPenAI backer Microsoft saw a surge in demand from corporate customers for the Azure OpenAI service. Microsoft has reported that 2,000 new clients signed up for the service in the first half of the current quarter, Bloomberg reported. 

This week, SAP SE (NYSE:SAP) CEO Christian Klein expressed colossal growth potential in generative AI technology.

SAP had shared plans to deepen collaboration with Microsoft in joint generative AI projects.

Price Action: MCO shares traded higher by 0.75% at $344.14 on the last check Thursday.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Hemp-Focused Wellness Co. Moves Closer To Profitability, Reports Flat 2023 Revenue, Increase In Gross Profit

By Jelena Martinovic
March 28, 12:04 PM
Hemp-focused consumer wellness company CV Sciences, Inc. (OTCQB: CVSI) announced on Thursday its financial results for the year ended Dec. 31, 2023. The San Diego-based company reported a gross margin of 44.3% for fiscal year 2023, representing an improvement from 34.2% for 2022. For the fourth quarter gross margin was 45.8%, representing a sequential improvement from 45.1% in the third quarter. "Our 2023 progress demonstrates our continuous commitment to innovation and cost-efficient execution as we move closer to profitability and positive cash flow," Joseph Dowling, CEO of CV Sciences, said. "As the CBD category consolidates, we have increased our market share in key sales channels, including the natural product retail channel. We will continue to focus our resources on new product development, as evidenced by our pet line expansion with our recent launch of pet chews for hip and joint health and calming care."

CVSI